FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor
This article was originally published in The Pink Sheet Daily
Executive Summary
Commissioner Hamburg places drug, biologics, devices and tobacco centers under Steven Spielberg's directorate; Deborah Autor becomes deputy commissioner for global regulatory operations and policy.
You may also be interested in...
FDA Again Taps Compliance Director For Globalization Post
Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.
FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office
Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”
Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says
The deputy commissioner detailed the steps involved in getting Vertex’s cystic fibrosis drug rapidly through the approval process and noted that FDA is working on innovative study designs and assessing how to better use diagnostics.